ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer Miscellaneous

  

Authors:	Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
Title:	ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
Keywords:	treatment outcome; genetics; mutation; chemotherapy, adjuvant; neoadjuvant therapy; antineoplastic agent; antineoplastic combined chemotherapy protocols; epidermal growth factor receptor 2; pathology; breast neoplasms; adjuvant chemotherapy; breast tumor; receptor, erbb-2; humans; human; female
Journal Title:	Annals of Surgical Oncology
Volume:	30
Issue:	13
ISSN:	1068-9265
Publisher:	Springer
Date Published:	2023-12-01
Start Page:	8469
End Page:	8470
Language:	English
DOI:	10.1245/s10434-023-14390-7
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85176495913&doi=10.1245%2fs10434-023-14390-7&partnerID=40&md5=c9da5515cdff24ec08c641d432ff68bd
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/211324